In this special report, insurance carriers and benefits advisors agree that the time has come to reassess corporate objectives to protect the sustainability of drug plans, which will increasingly be relied upon to provide coverage for higher-cost specialty drugs.

Get practical suggestions on how to weigh the corporate philosophy for drug benefits against the capacity to tolerate risk, and the implications for current—and untapped—drug plan management strategies across all drug claims.

 

Telus

Add a comment

Have your say on this topic! Comments that are thought to be disrespectful or offensive may be removed by our Benefits Canada admins. Thanks!

* These fields are required.
Field required
Field required
Field required